SEC EDGAR Filing Information

Form 10-K -- Annual report [Section 13 and 15(d), not S-K Item 405]

Period of Report: 2005-01-02
Filing Date Changed: 2005-03-15
Documents: 12
SEC Accession No.
0000950123-05-003140
Filing date: 2005-03-15
Accepted: 2005-03-15 16:26:48

Table of submitted documents:

Seq Type Document Size Description
1 10-K y06203e10vk.txt 63051 FORM 10-K
2 EX-10.H y06203exv10wh.txt 14773 DEFERRED FEE PLAN FOR DIRECTORS (AS AMENDED)
3 EX-10.Q y06203exv10wq.txt 3963 SUMMARY OF COMPENSATION
4 EX-12 y06203exv12.txt 2810 STATEMENT OF COMPUTATION OF RATIO OF EARNINGS
5 EX-13 y06203exv13.txt 214789 PAGES 28-66 OF ANNUAL REPORT TO SHAREHOLDERS
6 EX-21 y06203exv21.txt 17835 SUBSIDIARIES
7 EX-23 y06203exv23.txt 1389 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
8 EX-31.A y06203exv31wa.txt 4086 CERTIFICATION
9 EX-31.B y06203exv31wb.txt 4087 CERTIFICATION
10 EX-32.A y06203exv32wa.txt 1604 CERTIFICATION
11 EX-32.B y06203exv32wb.txt 1606 CERTIFICATION
12 EX-99.B y06203exv99wb.txt 7705 CAUTIONARY STATEMENT PURSUANT TO PRIVATE SECURITIES
0000950123-05-003140.txt 339045 Complete submission text file

Filer Information:

JOHNSON & JOHNSON (Filer) (0000200406)
IRS No.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0103
Type: 10-K | Act: 34 | File No.: 001-03215 | Film No.: 05682010
SIC: 2834 Pharmaceutical Preparations

  Assistant Director 1
Business Address
ONE JOHNSON & JOHNSON PLZ
NEW BRUNSWICK NJ 08933
7325242454
Mailing Address